TMEM210
gene geneOn this page
Summary
TMEM210 (transmembrane protein 210, HGNC:34059) is a protein-coding gene on chromosome 9q34.3, encoding Transmembrane protein 210 (A6NLX4).
Located in acrosomal vesicle.
Source: NCBI Gene 100505993 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001282477
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34059 |
| Approved symbol | TMEM210 |
| Name | transmembrane protein 210 |
| Location | 9q34.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000185863 |
| Ensembl biotype | protein_coding |
| Entrez | 100505993 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 1 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000413619, ENST00000427366, ENST00000430332, ENST00000535352
RefSeq mRNA: 1 — MANE Select: NM_001282477
NM_001282477
CCDS: CCDS65197
Canonical transcript exons
ENST00000413619 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001699715 | 137171940 | 137172056 |
| ENSE00003460194 | 137171414 | 137171443 |
| ENSE00003534205 | 137170858 | 137171164 |
| ENSE00003539221 | 137171641 | 137171776 |
Expression profiles
Bgee: expression breadth broad, 85 present calls, max score 95.19.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0143 / max 13.0815, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 103325 | 0.0057 | 3 |
| 103324 | 0.0044 | 3 |
| 103323 | 0.0043 | 3 |
Top tissues by expression
113 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 95.19 | gold quality |
| left testis | UBERON:0004533 | 95.18 | gold quality |
| testis | UBERON:0000473 | 94.35 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.86 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 64.45 | gold quality |
| minor salivary gland | UBERON:0001830 | 62.87 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 60.74 | gold quality |
| tonsil | UBERON:0002372 | 55.09 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 54.73 | gold quality |
| granulocyte | CL:0000094 | 54.28 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 52.14 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 51.42 | gold quality |
| cerebellum | UBERON:0002037 | 51.40 | gold quality |
| cerebellar cortex | UBERON:0002129 | 51.33 | gold quality |
| prostate gland | UBERON:0002367 | 49.96 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 49.52 | gold quality |
| right coronary artery | UBERON:0001625 | 48.64 | gold quality |
| transverse colon | UBERON:0001157 | 44.19 | gold quality |
| right uterine tube | UBERON:0001302 | 41.22 | silver quality |
| thoracic mammary gland | UBERON:0005200 | 39.48 | gold quality |
| metanephros cortex | UBERON:0010533 | 38.69 | silver quality |
| bone marrow cell | CL:0002092 | 38.62 | gold quality |
| lymph node | UBERON:0000029 | 38.23 | gold quality |
| rectum | UBERON:0001052 | 37.88 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 37.27 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 37.11 | silver quality |
| bone marrow | UBERON:0002371 | 36.77 | silver quality |
| fundus of stomach | UBERON:0001160 | 36.70 | gold quality |
| small intestine | UBERON:0002108 | 36.56 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.50 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem210 | ENSMUSG00000026963 |
| rattus_norvegicus | Tmem210 | ENSRNOG00000040275 |
Protein
Protein identifiers
Transmembrane protein 210 — A6NLX4 (reviewed: A6NLX4)
All UniProt accessions (2): A6NLX4, H3BNS5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane. Cytoplasmic vesicle. Secretory vesicle. Acrosome.
RefSeq proteins (1): NP_001269406* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028123 | TMEM210 | Family |
Pfam: PF15195
UniProt features (7 total): topological domain 2, signal peptide 1, chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NLX4-F1 | 60.60 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 13 (showing top):
GOCC_SECRETORY_GRANULE, GOCC_SECRETORY_VESICLE, GOCC_ACROSOMAL_VESICLE, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, chr9q34, GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP, GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN, GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP, GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP, GREB1_TARGET_GENES, HAY_BONE_MARROW_DENDRITIC_CELL, ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE, GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (3): acrosomal vesicle (GO:0001669), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| secretory granule | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
50 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM210 | SMIM9 | A6NGZ8 | 787 |
| TMEM210 | SMIM8 | Q96KF7 | 656 |
| TMEM210 | SLC25A41 | Q8N5S1 | 626 |
| TMEM210 | TOMM20L | Q6UXN7 | 598 |
| TMEM210 | CBY2 | Q8NA61 | 559 |
| TMEM210 | SLC25A2 | Q9BXI2 | 494 |
| TMEM210 | RASEF | Q8IZ41 | 493 |
| TMEM210 | PLCH1 | Q4KWH8 | 447 |
| TMEM210 | THEMIS2 | Q5TEJ8 | 447 |
| TMEM210 | PDZD8 | Q8NEN9 | 433 |
| TMEM210 | PLEKHB1 | Q9UF11 | 400 |
| TMEM210 | ZMYND8 | Q9ULU4 | 370 |
| TMEM210 | PSMD12 | O00232 | 367 |
| TMEM210 | LDHAL6B | Q9BYZ2 | 353 |
| TMEM210 | C1orf141 | Q5JVX7 | 349 |
| TMEM210 | CTXND2 | A0A1B0GV90 | 349 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GU29, A6NLX4, A6QNY1, A9CBA0, B7ZWI3, O14669, O88472, P14784, P16297, P25918, P26896, Q0VFL4, Q13651, Q32M26, Q38J84, Q38J85, Q3SYS8, Q58CT8, Q5BK39, Q5EAA5, Q5HZE8, Q5NCP0, Q5RCL0, Q64322, Q68DV7, Q6AXS2, Q6AXU5, Q6NUJ2, Q6UWV7, Q86UW2, Q8BHB3, Q8BLR5, Q8BSU2, Q8C353, Q8C708, Q8K1T1, Q8MII8, Q8N6P7, Q8NET5, Q8R182
Diamond homologs: A6NLX4, Q9D2F0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
602 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:137170969:AGC:A | donor_gain | 1.0000 |
| 9:137170977:A:AC | donor_gain | 1.0000 |
| 9:137170978:C:CC | donor_gain | 1.0000 |
| 9:137170981:A:AC | donor_gain | 1.0000 |
| 9:137170982:G:C | donor_gain | 1.0000 |
| 9:137171009:T:TA | donor_gain | 1.0000 |
| 9:137171444:C:CC | acceptor_gain | 1.0000 |
| 9:137171639:ACC:A | donor_gain | 1.0000 |
| 9:137171640:CCC:C | donor_gain | 1.0000 |
| 9:137171010:C:CA | donor_gain | 0.9900 |
| 9:137171024:T:TA | donor_gain | 0.9900 |
| 9:137171078:T:TA | donor_gain | 0.9900 |
| 9:137171160:CCAAC:C | acceptor_gain | 0.9900 |
| 9:137171161:CAACC:C | acceptor_gain | 0.9900 |
| 9:137171166:T:C | acceptor_loss | 0.9900 |
| 9:137171440:TTCA:T | acceptor_gain | 0.9900 |
| 9:137171442:CA:C | acceptor_gain | 0.9900 |
| 9:137171636:CGCA:C | donor_loss | 0.9900 |
| 9:137171637:GCA:G | donor_loss | 0.9900 |
| 9:137171639:A:AC | donor_gain | 0.9900 |
| 9:137171640:C:CC | donor_gain | 0.9900 |
| 9:137171641:C:A | donor_gain | 0.9900 |
| 9:137171773:CCAG:C | acceptor_gain | 0.9900 |
| 9:137171774:CAG:C | acceptor_gain | 0.9900 |
| 9:137171774:CAGC:C | acceptor_gain | 0.9900 |
| 9:137171777:C:CC | acceptor_gain | 0.9900 |
| 9:137171161:CAAC:C | acceptor_gain | 0.9800 |
| 9:137171163:ACC:A | acceptor_loss | 0.9800 |
| 9:137171164:CCTG:C | acceptor_loss | 0.9800 |
| 9:137171165:C:A | acceptor_loss | 0.9800 |
AlphaMissense
935 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:137171691:G:C | S58R | 0.994 |
| 9:137171691:G:T | S58R | 0.994 |
| 9:137171693:T:G | S58R | 0.994 |
| 9:137171697:A:C | S56R | 0.990 |
| 9:137171697:A:T | S56R | 0.990 |
| 9:137171699:T:G | S56R | 0.990 |
| 9:137171690:A:G | C59R | 0.989 |
| 9:137171705:C:G | G54R | 0.969 |
| 9:137171704:C:T | G54D | 0.957 |
| 9:137171742:G:C | S41R | 0.956 |
| 9:137171742:G:T | S41R | 0.956 |
| 9:137171744:T:G | S41R | 0.956 |
| 9:137171684:A:G | C61R | 0.955 |
| 9:137171677:A:T | L63H | 0.952 |
| 9:137171743:C:A | S41I | 0.949 |
| 9:137171680:G:T | A62D | 0.937 |
| 9:137171722:A:T | L48H | 0.931 |
| 9:137171695:G:T | A57D | 0.925 |
| 9:137171677:A:C | L63R | 0.921 |
| 9:137171710:A:C | L52R | 0.917 |
| 9:137171668:A:T | V66E | 0.909 |
| 9:137171722:A:C | L48R | 0.909 |
| 9:137171722:A:G | L48P | 0.908 |
| 9:137171725:G:T | A47D | 0.906 |
| 9:137171674:A:T | V64D | 0.903 |
| 9:137171746:A:T | L40H | 0.902 |
| 9:137171688:G:C | C59W | 0.900 |
| 9:137171659:C:T | G69D | 0.899 |
| 9:137171660:C:G | G69R | 0.887 |
| 9:137171716:A:T | V50E | 0.883 |
dbSNP variants (sampled 300 via entrez): RS1000093890 (9:137171173 C>A,G,T), RS1000146335 (9:137170959 A>G), RS1001159501 (9:137171962 G>A), RS1001720589 (9:137173919 CCAGGCGCAGCTCA>C), RS1002489842 (9:137173114 C>T), RS1002664885 (9:137172279 G>A), RS1002712150 (9:137171930 G>A), RS1002868670 (9:137172905 G>A), RS1003231422 (9:137172215 G>A), RS1004179331 (9:137173504 T>G), RS1005843039 (9:137172380 T>A,C), RS1006268517 (9:137173100 T>G), RS1006676878 (9:137170713 G>A), RS1006972093 (9:137170496 G>A), RS1008408215 (9:137173715 G>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| benzo(e)pyrene | decreases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Methapyrilene | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.